Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1024 | 1040 | 1039 | 1111 | 1259 | 1759 |
Fund Return | 2.43% | 3.99% | 3.87% | 3.56% | 4.71% | 5.81% |
Place in category | 253 | 519 | 295 | 326 | 409 | 156 |
% in Category | 36 | 77 | 51 | 60 | 86 | 56 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UBS CH Institutional Fund 2 EquiP2X | 8.9B | 18.23 | 8.69 | 12.63 | ||
UBS CH Institutional Fund 2 EquiPAX | 4.17B | 17.19 | 7.06 | 9.79 | ||
UBS CH Vitainvest 50 World U | 4.4B | 2.45 | -0.62 | 2.66 | ||
UBS CH Institutional Fund 2 EquUSAX | 2.23B | 11.99 | 9.95 | 12.62 | ||
UBS CH Institutional Fund 2 EquiSCB | 2.17B | 8.08 | -1.33 | 7.27 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0033782431 | 2.49B | 3.85 | 3.74 | 6.24 | ||
Raiffeisen Futura Swiss Stock A | 2.2B | 2.12 | 2.41 | 6.12 | ||
UBS CH Equity Fund Swiss Income CHQ | 1.85B | 2.59 | 4.20 | 6.41 | ||
UBAM Swiss Equity AD CHF Inc | 1.79B | 7.99 | -0.55 | 5.90 | ||
UBAM Swiss Equity A CHF Acc | 1.79B | 3.61 | -0.24 | 5.48 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Roche Holding Participation | CH0012032048 | 9.77 | 239.70 | -1.20% | |
Nestle | CH0038863350 | 9.34 | 95.60 | -2.47% | |
Novartis | CH0012005267 | 9.33 | 94.30 | -0.68% | |
UBS Group | CH0244767585 | 9.03 | 28.03 | -1.37% | |
Zurich Insurance Group | CH0011075394 | 7.67 | 476.40 | -0.67% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review